367 related articles for article (PubMed ID: 19261632)
21. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM; van Garderen E; Schalken JA; Nederbragt H
J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
[TBL] [Abstract][Full Text] [Related]
22. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
Klopfleisch R; Klose P; Gruber AD
Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
[TBL] [Abstract][Full Text] [Related]
23. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands.
Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A
Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176
[TBL] [Abstract][Full Text] [Related]
26. The role of CD44 adhesion factor in canine mammary carcinomas.
Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
[TBL] [Abstract][Full Text] [Related]
27. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
28. The novel carbohydrate tumor antigen C2-O-sLe x is upregulated in canine gastric carcinomas.
Janke L; Carlson CS; St Hill CA
Vet Pathol; 2010 May; 47(3):455-61. PubMed ID: 20375429
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands.
Klopfleisch R; Gruber AD
Res Vet Sci; 2009 Aug; 87(1):91-6. PubMed ID: 19185891
[TBL] [Abstract][Full Text] [Related]
30. Simple mucins (T, sialosyl-T, Tn and sialosyl-Tn) are not diagnostic for malignant breast lesions.
Reed W; Bryne M; Clausen H; Dabelsteen E; Nesland JM
Anticancer Res; 1994; 14(2B):609-15. PubMed ID: 7516636
[TBL] [Abstract][Full Text] [Related]
31. Expression of class II beta-tubulin by proliferative myoepithelial cells in canine mammary mixed tumors.
Arai K; Nakano H; Shibutani M; Naoi M; Matsuda H
Vet Pathol; 2003 Nov; 40(6):670-6. PubMed ID: 14608020
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables.
Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F
J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
[TBL] [Abstract][Full Text] [Related]
34. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.
Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM
Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219
[TBL] [Abstract][Full Text] [Related]
35. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
36. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas.
Ryuko K; Iwanari O; Kitao M; Moriwaki S
Gynecol Oncol; 1993 May; 49(2):215-24. PubMed ID: 8504990
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer.
Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
J Surg Oncol; 1996 Jul; 62(3):171-6. PubMed ID: 8667623
[TBL] [Abstract][Full Text] [Related]
39. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
40. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]